Vanda Pharmaceuticals (VNDA) Stock Chart & Stock Price History $4.77 -0.04 (-0.83%) Closing price 04:00 PM EasternExtended Trading$4.74 -0.03 (-0.73%) As of 06:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Vanda Pharmaceuticals Stock Price Performance 5 Day Performance0.00%1 Month Performance+1.27%3 Month Performance-0.83%6 Month Performance+0.63%Year-To-Date Performance-0.42%1 Year Performance+23.58% Receive VNDA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vanda Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address VNDA Stock Chart for Wednesday, March, 26, 2025 VNDA Chart by TradingViewRemove Ads Vanda Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/26/2025$4.81$4.77-0.83%$4.80$4.65666,768 shs$278.17 million03/25/2025$4.82$4.81-0.21%$4.87$4.74342,759 shs$280.50 million03/24/2025$4.77$4.82+1.05%$4.86$4.75371,987 shs$281.08 million03/21/2025$4.92$4.77-3.05%$4.96$4.75606,629 shs$278.17 million03/20/2025$4.94$4.92-0.40%$5.01$4.84350,989 shs$286.92 million03/19/2025$4.99$4.94-1.00%$5.04$4.85316,958 shs$288.08 million03/18/2025$5.08$4.99-1.77%$5.02$4.87454,055 shs$291.00 million03/17/2025$4.98$5.08+2.01%$5.16$4.95450,168 shs$296.25 million03/14/2025$4.92$4.98+1.22%$5.07$4.91637,849 shs$290.41 million03/13/2025$4.95$4.92-0.61%$5.05$4.84357,602 shs$286.92 million Get the Latest News and Ratings for VNDA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vanda Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 03/12/2025$4.98$4.95-0.60%$5.10$4.86658,725 shs$288.66 million03/11/2025$4.71$4.98+5.73%$5.00$4.65681,570 shs$290.41 million03/10/2025$4.85$4.71-2.89%$4.83$4.66435,618 shs$274.67 million03/07/2025$4.91$4.85-1.22%$5.06$4.82611,200 shs$286.33 million03/06/2025$5.13$4.91-4.29%$5.19$4.89873,301 shs$286.33 million03/05/2025$4.81$5.13+6.65%$5.16$4.791.25 million shs$299.16 million03/04/2025$4.72$4.81+1.91%$4.83$4.62695,279 shs$280.50 million03/03/2025$4.76$4.72-0.84%$4.86$4.60806,077 shs$275.25 million02/28/2025$4.70$4.76+1.28%$4.79$4.65487,887 shs$277.58 million02/27/2025$4.71$4.70-0.21%$4.90$4.70608,868 shs$274.09 million02/26/2025$4.46$4.71+5.61%$4.83$4.561.45 million shs$274.67 million02/25/2025$4.35$4.46+2.53%$4.50$4.30604,138 shs$260.09 million Related Companies Geron Stock Chart Innoviva Stock Chart Myriad Genetics Stock Chart Zenas Biopharma Stock Chart Rigel Pharmaceuticals Stock Chart Emergent BioSolutions Stock Chart Verastem Stock Chart Codexis Stock Chart XOMA Stock Chart Ironwood Pharmaceuticals Stock Chart Receive VNDA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vanda Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VNDA) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredHere’s Why Tesla Insiders are Dumping SharesTesla has been on a losing streak ever since Elon Musk first visited the White House in early 2025. Our res...Behind the Markets | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vanda Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vanda Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
